Reps. Arrington, Peters Interested In Linking Drug Exclusivity To Value

By John Wilkerson / November 19, 2021 at 1:02 PM
Rep. Jodey Arrington (R-TX) said Wednesday (Nov. 17) the government should vary drug exclusivity periods based on the value of drugs to society, and Rep. Scott Peters (D-CA) said he’d like to work with Arrington on that idea. However, it’s unclear whether there will be much appetite for taking on additional drug pricing reforms now that House Democrats have passed the scaled-back Medicare price negotiation deal largely brokered by Peters as part of their Build Back Better legislation. The crux...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.